Can virtual doula sessions and home monitoring prevent preeclampsia in black women?
NCT ID NCT07491510
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 5 times
Summary
This study will test a telehealth group prenatal care program called Centering HER in 72 low-income, predominantly Black pregnant women in Kansas who are at moderate or high risk for preeclampsia. Participants will receive routine care plus seven doula-led virtual group sessions, a Bluetooth blood pressure cuff and scale, and optionally an Apple Watch. The goal is to see if this program improves blood pressure monitoring and aspirin use, and ultimately reduces early-onset preeclampsia.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- behavioral intervention: telehealth group prenatal care (Centering HER) with doula-led sessions, Bluetooth BP cuff/scale, and optional Apple Watch
- What this could lead to
- If successful, this program could offer a practical way to reduce early-onset preeclampsia in high-risk, low-income Black women through better monitoring and aspirin adherence.
- What could go wrong
- This is a small, early feasibility study (72 participants) that has not yet started recruiting. It tests a behavioral program, not a drug, so the impact may be limited and may not apply to other populations or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASPIRIN PROPHYLAXIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Kansas Medical Center
Kansas City, Kansas, 66101, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.